Results 321 to 330 of about 2,605,751 (360)
Some of the next articles are maybe not open access.
The Lancet, 2005
Stem cells derived from adult and embryonic sources have great therapeutic potential, but much research is still needed before their clinical use becomes commonplace. There is debate about whether adult stem cells can be used instead of those derived from embryos.
A, Vats +4 more
openaire +3 more sources
Stem cells derived from adult and embryonic sources have great therapeutic potential, but much research is still needed before their clinical use becomes commonplace. There is debate about whether adult stem cells can be used instead of those derived from embryos.
A, Vats +4 more
openaire +3 more sources
New England Journal of Medicine, 1978
Blood cells, like blossoms of a floribunda, arise together from a single branch. Clinicians have long assumed that granulocytes, megakaryocytes and erythroid cells have a common origin because all three cell lines may be involved to a varying degree in the many forms of myeloproliferative disease.
openaire +3 more sources
Blood cells, like blossoms of a floribunda, arise together from a single branch. Clinicians have long assumed that granulocytes, megakaryocytes and erythroid cells have a common origin because all three cell lines may be involved to a varying degree in the many forms of myeloproliferative disease.
openaire +3 more sources
Nature Reviews Cancer, 2012
A paper in Cell identifies a subpopulation of intestinal stem cells that are characterized by the expression of LRIG1, which the authors show is a tumour suppressor.
openaire +3 more sources
A paper in Cell identifies a subpopulation of intestinal stem cells that are characterized by the expression of LRIG1, which the authors show is a tumour suppressor.
openaire +3 more sources
Journal of Leukocyte Biology, 1995
Abstract Stem cell factor (SCF) is the ligand for the tyrosine kinase receptor okit, which is expressed on both primitive and mature hematopoietic progenitor cells. In vitro, SCF synergizes with other growth factors, such as granulocyte colony-stimulating factor (G–CSF), granulocyte macrophage–colony-stimulating factor, and interleukin-3
Sidney Vaughn Suggs +3 more
openaire +3 more sources
Abstract Stem cell factor (SCF) is the ligand for the tyrosine kinase receptor okit, which is expressed on both primitive and mature hematopoietic progenitor cells. In vitro, SCF synergizes with other growth factors, such as granulocyte colony-stimulating factor (G–CSF), granulocyte macrophage–colony-stimulating factor, and interleukin-3
Sidney Vaughn Suggs +3 more
openaire +3 more sources
Stem Cells and Cancer Stem Cells
2015Nowadays, the definition “cancer stem cells” (CSCs) is widely accepted in the science community. Although, some authors think that this is a new definition in biology, the idea of CSCs has existed for more than 50 years. In recent years, the relations between “stem cells” and “cancer stem cells” gradually explored.
openaire +2 more sources
Pancreatology, 2007
In this issue, 'Pancreatology and the Web' focuses on stem cell research, one of the 21st century's most exciting areas of science. Stem cell research has been advancing our knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms.
openaire +2 more sources
In this issue, 'Pancreatology and the Web' focuses on stem cell research, one of the 21st century's most exciting areas of science. Stem cell research has been advancing our knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms.
openaire +2 more sources
2016
This book presents state of the art knowledge regarding the pathophysiology and diagnosis of fecal incontinence and describes and illustrates all relevant treatment techniques. In addition to the approaches that have been the mainstay of treatment of fecal incontinence to date, it covers recent innovations and emerging options, including ...
Ledda M, Giori A, Lisi A
openaire +2 more sources
This book presents state of the art knowledge regarding the pathophysiology and diagnosis of fecal incontinence and describes and illustrates all relevant treatment techniques. In addition to the approaches that have been the mainstay of treatment of fecal incontinence to date, it covers recent innovations and emerging options, including ...
Ledda M, Giori A, Lisi A
openaire +2 more sources